SCHEMBL442743

SCHEMBL442743

[H+].[H+].[Na+].[Na+]

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10578665 1.00
SCHEMBL93542 1.00
SCHEMBL27657 1.00
SCHEMBL7457068 1.00
SCHEMBL8333775 1.00
SCHEMBL157767 1.00
SCHEMBL1410012 1.00
SCHEMBL11525437 1.00
SCHEMBL8333713 1.00
Fluoride Ion SCHEMBL35953 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4248756-A1 ACID LEAVENING AGENT HAVING HIGH NEUTRALIZING VALUE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Yunnan Addiphos Technology Co., Ltd. (CN) 2023-09-27 EP claimed
CN-110521839-A A kind of mellowness snowflake shortcake and preparation method thereof JIANGSU HAODE FOOD CO LTD 2019-12-03 CN claimed
CN-110367314-A A kind of donkey-hide gelatin cake and its preparation process 山东福牌阿胶股份有限公司 2019-10-25 CN claimed
CN-110361245-A Colour reagent box and its application is immunized in a kind of DAB 河南赛诺特生物技术有限公司 2019-10-22 CN claimed
CN-110313503-A A kind of donkey-hide gelatin shortbread type biscuit and its preparation process 山东福牌阿胶股份有限公司 2019-10-11 CN claimed
CN-110292108-A A method of improving chicken sausage noodle roll utilization rate 光泽县泽农生物科技有限公司 2019-10-01 CN claimed
CN-110101026-A A kind of quantitatively stew in soy sauce and the spiced beef and preparation method thereof steamed 吉林大学 2019-08-09 CN claimed
CN-109749150-A A kind of high intensity yielding rubber 江苏骆氏减震件有限公司 2019-05-14 CN claimed
CN-106450300-B A kind of ferric sodium pyrophosphate material and its preparation method and application with flower-like structure 中南大学 2019-05-03 CN claimed
CN-109259057-A It is a kind of it is compound wrap up in powder and its processing method and using this wrap up in powder processing oyster method 苏州闻达食品配料有限公司 2019-01-25 CN claimed
US-20150111809-A1 Fragrance Delivery Product COURTESY CREATIONS LLC 2015-04-23 US claimed
EP-1054670-B1 USE OF CHELATING AGENTS IN THE TREATMENT OF ATHEROSCLEROTIC CONDITIONS AMERSHAM HEALTH AS (NO) 2005-03-09 EP claimed
US-6310051-B1 BY ADMINISTERING A DIPYRIDOXYL BASED CHELATING AGENT, OR A METAL CHELATE OR SALT THEREOF, SUCH AS N,N'-BIS-(PYRIDOXAL-5-PHOSPHATE)-ETHYLENEDIAMINE-N,N'-DIACETIC ACID NYCOMED IMAGING AS (NO) 2001-10-30 US claimed
US-5935566-A AVOIDING VISIBLE PARTICULATE MATTER FORMATION IN AN AQUEOUS ALFA INTERFERON FORMULATION HAVING DISODIUM DIHYDROGEN ETHYLENEDIAMINETETRAACETATE AS A CHELATING AGENT, A SORBITAN MONO-9-OCTADECENOATE POLYOXYETHYLENE GLYCOL STABILIZER SCHERING CORPORATION (US) 1999-08-10 US claimed
EP-0777495-A1 STABLE, AQUEOUS ALFA INTERFERON SOLUTION FORMULATIONS SCHERING CORPORATION (US) 1997-06-11 EP claimed
WO-1996011018-A1 STABLE, AQUEOUS ALFA INTERFERON SOLUTION FORMULATIONS SCHERING CORPORATION (US) 1996-04-18 WO claimed
EP-0518956-A4 ANIMAL FEED ADDITIVE AND METHOD FOR INACTIVATING MYCOTOXINS PRESENT IN ANIMAL FEEDS 1993-01-27 EP claimed
EP-0518956-A1 ANIMAL FEED ADDITIVE AND METHOD FOR INACTIVATING MYCOTOXINS PRESENT IN ANIMAL FEEDS ENGELHARD CORPORATION (US) 1992-12-23 EP claimed
US-5165946-A Phyllosilicate minerals as mycotoxin deactivators and coated with sequestering agents ENGELHARD CORPORATION (US) 1992-11-24 US claimed
WO-1991013555-A1 ANIMAL FEED ADDITIVE AND METHOD FOR INACTIVATING MYCOTOXINS PRESENT IN ANIMAL FEEDS ENGELHARD CORPORATION (US) 1991-09-19 WO claimed